People with serious mental illness could one day be offered a nasal
spray of ketamine after a clinical trial showed the drug can rapidly
tackle bouts of severe depression and suicidal thoughts.
In just a matter of hours, doctors, and the patients themselves,
measured a significant improvement in symptoms of patients classed as
being at high risk of suicide.
The trial of antidepressant esketamine by Yale University researchers
and the manufacturer, Janssen, suggests it could be effective in
bridging the gap where conventional antidepressants take weeks to
be fully effective.
spray of ketamine after a clinical trial showed the drug can rapidly
tackle bouts of severe depression and suicidal thoughts.
In just a matter of hours, doctors, and the patients themselves,
measured a significant improvement in symptoms of patients classed as
being at high risk of suicide.
The trial of antidepressant esketamine by Yale University researchers
and the manufacturer, Janssen, suggests it could be effective in
bridging the gap where conventional antidepressants take weeks to
be fully effective.
No comments:
Post a Comment